CRBP
CorbusBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
CRBP vs peer average
85/100
CRBP vs. peer average (B vs. D)
Grade spread
C 2 · D 4 · F 4
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
IPHA is the first available peer comparator.
Prior-baseline Nectin-4 ADC development reference, not a like-for-like valuation peer because program design, tumor mix, and stage differ.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CRBP
Corbus
IPHA
Innate
Grade
B
D
Momentum
2
18
Value
58
46
Sentiment
68
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs IPHA
CRBP / IPHA
Grade Position
Above peers
CRBP vs. peer average (B vs. D)
85/100
Momentum
2
IPHAValue
58
CRBPSentiment
68
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CRBP
IPHA is the first peer returned for this comparison set.